NCT04520932View on ClinicalTrials.gov

Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine Tumors

NARecruitingINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

March 30, 2021

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2031

Conditions
Neuroendocrine Tumor of Pancreas (Disorder)Neuroendocrine Tumor Grade 1
Interventions
PROCEDURE

Radiofrequency ablation

RFA is performed under general anaesthesia, under high endoscopic echo-endoscopy (EEH), in left lateral decubitus position, using the StarMed generator from Taewong®.

Trial Locations (1)

13009

RECRUITING

Institut Paoli Calmettes, Marseille

All Listed Sponsors
lead

Institut Paoli-Calmettes

OTHER